Table 3 Prevalence of SEs and TSST1 encoding genes among various CoNS species and various clinical samples
Source | CoNS (n = 91) | |||||||
|---|---|---|---|---|---|---|---|---|
Catheter n (%) | Wound n (%) | Urine n (%) | Blood n (%) | Super antigenes | S. epidermidis (n = 49) | S. haemolyticus (n = 37) | S. saprophyticus (n = 5) | Total n (%) |
0 (0) | 0 (0) | 1 (3) | 1 (2.6) | SEA | 0 (0) | 2 (5.4) | 0 (0) | 2 (2.2) |
4 (30.8) | 1 (16.7) | 12 (36.4) | 8 (20.5) | SEB | 14 (28.6) | 8 (21.6) | 3 (60) | 25 (27.5) |
6 (46.2) | 3 (50) | 15 (45.5) | 20 (51.3) | SEC | 29 (59.2) | 13 (35.1) | 2 (40) | 44 (48.4) |
0 (0) | 0 (0) | 2 (6.1) | 1 (2.6) | SED | 2 (4.1) | 0 (0) | 1 (20) | 3 (3.3) |
1 (7.7) | 0 (0) | 8 (24.2) | 2 (5.1) | SEE | 7 (14.3) | 2 (5.4) | 2 (40) | 11 (12.1) |
0 (0) | 0 (0) | 4 (12.1) | 0 (0) | SEH | 2 (4.1) | 2 (5.4) | 0 (0) | 4 (4.4) |
0 (0) | 0 (0) | 2 (6.1) | 3 (7.7) | SEM | 2 (4.1) | 2 (5.4) | 1 (20) | 5 (5.5) |
2 (15.4) | 0 (0) | 12 (36.4) | 9 (23.1) | TST1 | 14 (28.6) | 8 (21.6) | 1 (20) | 23 (25.3) |